AUTHOR=Xu Lin , Che Xu 

TITLE=Sorafenib combined with tarexib for first-line treatment of unresectable hepatocellular carcinoma and its predictive role and correlation with PD-L1 CTCs

JOURNAL=Frontiers in Oncology

VOLUME=14

YEAR=2024

URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1478596

DOI=10.3389/fonc.2024.1478596

ISSN=2234-943X